同日,新华制药又有2款重磅药物获批上市

北京药研汇
Mar 04

年味未过,新华制药迎来大爆发。同日,2款涉及糖尿病、帕金森病治疗的重磅药获批上市。2026年2月28日,据中国国家药品监督管理局(NMPA)官网最新显示,山东新华制药股份有限公司申报的恩他卡朋片获批上市,视同过评。据公开资料显示,恩他卡朋片是一款儿茶酚-O-甲基转移酶(COMT)抑制剂,用于帕金森病的辅助治疗。同日,山东新华全资子公司申报的沙格列汀二甲双胍缓释片(Ⅲ)获批上市,视同过评。据公开资料...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10